Related references
Note: Only part of the references are listed.Prognostic value of Iroquois homeobox 1 methylation in non-small cell lung cancers
Ji Yun Lee et al.
GENES & GENOMICS (2020)
Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas
Chundi Gao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Iroquois Homeobox 1 Acts as a True Tumor Suppressor in Multiple Organs by Regulating Cell Cycle Progression
In Hye Jung et al.
NEOPLASIA (2019)
Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
Verena Deutschmeyer et al.
CLINICAL EPIGENETICS (2019)
Iroquois Homeodomain transcription factors in ventricular conduction system and arrhythmia
Wenyu Hu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data
Vijayachitra Modhukur et al.
EPIGENOMICS (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
CDD/SPARCLE: functional classification of proteins via subfamily domain architectures
Aron Marchler-Bauer et al.
NUCLEIC ACIDS RESEARCH (2017)
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
Antje M. Richter et al.
CLINICAL EPIGENETICS (2017)
Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
Steffen Kiehl et al.
SCIENTIFIC REPORTS (2017)
Irx1 regulates dental outer enamel epithelial and lung alveolar type II epithelial differentiation
Wenjie Yu et al.
DEVELOPMENTAL BIOLOGY (2017)
The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms
Tanja Haag et al.
BMC CANCER (2016)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer
Mark O. Kitchen et al.
EPIGENETICS (2016)
Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population
Krista A. Zanetti et al.
LUNG CANCER (2016)
The IRX1/HOXA connection: insights into a novel t(4;11)-specific cancer mechanism
Alessa Kuehn et al.
ONCOTARGET (2016)
Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis
Xinhua Wang et al.
SCIENTIFIC REPORTS (2016)
The emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series)
Jessica H. Huston et al.
PULMONARY CIRCULATION (2016)
Glycodelin: A New Biomarker with Immunomodulatory Functions in Non-Small Cell Lung Cancer
Marc A. Schneider et al.
CLINICAL CANCER RESEARCH (2015)
IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling
Jinchang Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue
Shuguang Huang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions
Joel L. Weissfeld et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
CTCF/cohesin-binding sites are frequently mutated in cancer
Riku Katainen et al.
NATURE GENETICS (2015)
Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer
Anna Diez-Villanueva et al.
EPIGENETICS & CHROMATIN (2015)
Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding
Georgina Victoria-Acosta et al.
SCIENTIFIC REPORTS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Identifying novel biomarkers of gastric cancer through integration analysis of single nucleotide polymorphisms and gene expression profile
Tao Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2015)
Diverse cells at the origin of lung adenocarcinoma
Samuel P. Rowbotham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Quantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics
Liyan Wan et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Iroquois Homeodomain Transcription Factors in Heart Development and Function
Kyoung-Han Kim et al.
CIRCULATION RESEARCH (2012)
Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors
Jie Wang et al.
GENOME RESEARCH (2012)
The tumor suppressor role of CTCF
Francesco Paolo Fiorentino et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
RASSF10 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin but Uncommon in Nevus Cell Nevi
Peter Helmbold et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
From tissue to molecular phenotyping: pre-analytical requirements Heidelberg experience
Thomas R. Muley et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2012)
Increased DNA methylation of neuropsychiatric genes occurs in borderline personality disorder
Gerhard Dammann et al.
EPIGENETICS (2011)
Identification of a Novel Biomarker, SEMA5A, for Non-Small Cell Lung Carcinoma in Nonsmoking Women
Tzu-Pin Lu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma
X. Guo et al.
ONCOGENE (2010)
The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia
Chao Agnes Hsiung et al.
PLOS GENETICS (2010)
Disruption of Transforming Growth Factor-β Signaling by Five Frequently Methylated Genes Leads to Head and Neck Squamous Cell Carcinoma Pathogenesis
Kristi L. Bennett et al.
CANCER RESEARCH (2009)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Epigenetic Silencing of the p16INK4a Tumor Suppressor Is Associated with Loss of CTCF Binding and a Chromatin Boundary
Michael Witcher et al.
MOLECULAR CELL (2009)
Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma
Kristi L. Bennett et al.
CANCER RESEARCH (2008)
Lung cancer susceptibility locus at 5p15.33
James D. McKay et al.
NATURE GENETICS (2008)
GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor
Davis Sean et al.
BIOINFORMATICS (2007)
Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF
Inti A. De la Rosa-Velazquez et al.
CANCER RESEARCH (2007)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Rasgrf1 imprinting is regulated by a CTCF-dependent methylation-sensitive enhancer blocker
B Yoon et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Identification of a new target region by loss of heterozygosity at 5p15.33 in sporadic gastric carcinomas: genotype and phenotype related
Y Lu et al.
CANCER LETTERS (2005)
Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter
M Strunnikova et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
CpG island methylation and expression of tumour-associated genes in lung carcinoma
R Dammann et al.
EUROPEAN JOURNAL OF CANCER (2005)
Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer
SF Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Iroquois genes:: genomic organization and function in vertebrate neural development
JL Gómez-Skarmeta et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
R Dammann et al.
NATURE GENETICS (2000)
CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus
AT Hark et al.
NATURE (2000)